Homeostatic model assessment indices in evaluation of insulin resistance and secretion in hemodialysis patients

Medical Science Monitor

Volumn 19, Issue 1, 2013, Pages 592-598

  Niemczyk, Stanisław ^a   Szamotulska, Katarzyna ^a   Giers, Kinga ^a   Jasik, Mariusz ^a   Bartoszewicz, Zbigniew ^a   Romejko Ciepielewska, Katarzyna ^a   Paklerska, Ewa ^a   Gomółka, Malgorzata ^a   Matuszkiewicz Rowińska, Joanna ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Chronic renal failure; Disposition index; Homeostatic model assessment; Insulin resistance; cell function

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GLUCOSE BLOOD LEVEL; HEMODIALYSIS; HOMEOSTASIS; HUMAN; IMMUNORADIOMETRIC ASSAY; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; KIDNEY FAILURE; MALE; PANCREAS ISLET CELL FUNCTION;

EID: 84880574338     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.883978     Document Type: Article

References (41)

1. Fliser D, Pacini G, Engelleiter R et al: Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease. Kidney Int, 1998; 53(5): 1343-47
2. Caglar K, Yilmaz MI, Sonmez A et al: ADMA, proteinuria, and insulin resistance in non-diabetic stage I chronic kidney disease. Kidney Int, 2006; 70(4): 781-87
3. Kobayashi S, Maesato K, Moriya H et al: Insulin resistance in patients with chronic kidney disease. Am J Kidney Dis, 2005; 45(2): 275-80
4. Kobayashi S, Maejima S, Ikeda T, Nagase M: Impact of dialysis therapy on insulin resistance in end-stage renal disease: comparison of haemodialysis and continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant, 2000; 15(1): 65-70
5. Stefanović V, Nesić V, Stojimirović B: Treatment of insulin resistance in uremia. Int J Artif Organs, 2003; 26(2): 100-4
6. Atamer A, Alisir Ecder S et al: Relationship between leptin, insulin resistance, insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in patients with chronic kidney disease. J Int Med Res, 2008; 36(3): 522-28
7. Sit D, Kadiroglu AK, Kayabasi H, Yilmaz ME: The prevalence of insulin resistance in nondiabetic nonobese patients with chronic kidney disease. Adv Ther, 2006; 23(6): 988-98
8. Bastürk T, Unsal A: Is Insulin Resistance a Risk Factor for the Progression of Chronic Kidney Disease? Kidney Blood Press Res, 2011; 34: 111-15
9. Moller DE, Flier JS: Insulin resistance - mechanisms, syndromes, and implications. N Engl J Med, 1991; 325: 938-48
10. Cheng HT, Huang JW, Chiang CK et al: Metabolic Syndrome and Insulin Resistance as Risk Factors for Development of Chronic Kidney Disease and Rapid Decline in Renal Function in Elderly J Clin Endocrinol Metab, 2012, 97(4): 1268-76
11. DeFronzo RA, Alvestrand A, Smith D et al: Insulin resistance in uremia. J Clin Invest, 1981; 67(2): 563-68
12. Kanauchi M, Akai Y, Hashimoto T: Validation of simple indices to assess insulin sensitivity and pancreatic beta cell function in patients with renal dysfunction. Nephron, 2002; 92: 713-15
13. Liao MT, Sung CC, Hung KC et al: Insulin resistance in patients with chronic Kidney Disease. J Biomed Biotechnology, 2012; 2012: 691369
14. Straczkowski M, Stepień A, Kowalska I, Kinalska I: Comparison of simple indices of insulin sensitivity using the euglicemic hyperinsulinemic clamp technique. Med Sci Monit, 2004; 10(8): CR480-84
15. Bonora E, Targher G, Alberiche M et al: Homeostatic model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensivity: studies in subjects with various degrees of glucose tolerance and insulin sensivity. Diabetes Care, 2000; 23(1): 57-63
16. Shoi T, Emoto M, Nishizawa Y: HOMA index to assess insulin resistance in renal failure patients. Nephron, 2001; 89: 348-49
17. Smith D, DeFronzo RA: Insulin resistance in uremia mediated by post binding defects. Kidney Int, 1982; 22(1): 54-62
18. Guarnieri G, Zanetti M, Vinci P et al: Insulin resistance in chronic uremia. J Ren Nutr, 2009; 19(1): 20-24
19. Hung AM, Ikizler TA: Factors determining insulin resistance in chronic hemodialysis patients. Contrib Nephrol, 2011; 171: 127-34
20. Steivinkel P, Heimburger O, Lonnqvist F: Serum leptin concentrations correlate to plasma insulin concentrations independent of body fat content in chronic renal failure. Nephrol Dial Transpl, 1997; 12(7): 1321-25
21. Ziegelmeier M, Bachmann A, Seeger J et al: Adipokines influencing metabolic and cardiovascular disease are differentially regulated in maintenance hemodialysis. Metabolism, 2008; 57(10): 1414-21
22. Pham H, Utzschneider KM, de Boer IH: Measurement of insulin resistance in chronic kidney disease. Curr Opin Nephrol Hypertens, 2011; 20(6): 640-46
23. Borai A, Livingstone C, Kaddam I, Ferens G: Selection of the appropriate method for the assessment of insulin resistance. BMC Medical Research Methodology, 2011; 11: 158-68
24. Banerjee D, Recio-Mayoral A, Chitalia N, Kaski JC: Insulin resistance, inflamation, and vascular disease in nondiabetic predialysis chronic kidney disease patients. Clin Cardiol, 2011; 34(6): 360-65
25. Wallace TM, Levy JC, Matthews DR: Use and abuse of HOMA modeling. Diabetes Care, 2004; 27: 1487-95
26. Levy JC, Matthews DR, Hermans MP: Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care December, 1998; 21(12): 2191-92
27. Caumo A, Perseghin G, Brunani A, Luzi L: New insights on the simultaneous assessment of insulin sensitivity and beta-cell function with the HOMA2 method. Diabetes Care, 2006; 29(12): 2733-34
28. Cobelli C, Toffolo GM, Man CD et al: Assessment of beta-cell function in humans, simultaneously with insulin sensitivity and hepatic extraction, from intravenous and oral glucose tests. Am J Physiol Endocrinol Metab, 2007; 293: E1-15
29. Heald AH, Anderson SG, Patel J et al: Change in pancreatic B-cell function (HOMA B) varies in different populations with similar genetic backgrounds but different environments. Diabet Ned, 2007; 24: 145-53
30. Matthews DR, Hooker JP, Rudenski AS et al: Homeostasis model assessment: insulin resistance and B-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia, 1985; 28: 412-19
31. Costa A, Rios M, Casamitjana R et al: High prevalence of abnormal glucose tolerance and metabolic disturbances in first degree relatives of NIDDM patients: a study in Catalonia, a Mediterranean community. Diabetes Res Clin Pract, 1998; 41: 191-96
32. da Silva RC, Miranda WL, Chacra AR, Dib SA: Insulin resistance, beta-cell function, and glucose tolerance in Brazilian adolescents with obesity or risk factors for type 2 diabetes mellitus. J. Diabetes Complications, 2007; 21: 84-89
33. Festa A, Williams K, Hanley AY, Haffner SM: Beta-cell dysfunction in subjects with impaired glucose tolerance and early type 2 diabetes: comparison of surrogate markers with first-phase insulin secretion from an intravenous glucose tolerance test. Diabetes, 2008; 57: 1638-44
34. Haffner SM, Miettinen H, Stern NP: The homeostasis model in the San Antonio Heart Study. Diabetes Care, 1997; 20: 1087-92
35. Haffner SM, Kennedy E, Gonzalez C et al: A prospective analysis of the HOMA model: the Mexico City Diabetes Study. Diabetes Care, 1996; 19: 1138-41
36. Hermans MP, Levy JC, Morris RJ, Turner RC: Comparison of tests of B-cell function across a range of glucose tolerance from normal to diabetes. Diabetes, 1999; 48: 1779-86
37. Pfutzner A, Derwahl M, Jacob S et al: Limitations of HOMA-B score for assessment of beta-cell functionality in interventional trials - results from PIOglim study. Diabetes Thechnol Ther, 2010; 12: 599-604
38. Herzberg-Schafer SA, Staiger H, Heni M et al: Evaluation of fasting state-/ oral glucose tolerance test-derived measures of insulin release for the detection of genetically impaired B-cell function. PLoS One, 2010; 5(12): e14194
39. Tuzcu A, Bahceci M, Yilmaz ME et al: The determination of insulin sensitivity in hemodialysis and continuous ambulatory peritoneal dialysis in nondiabetic patients with end stage renal disease. Saudi Med J, 2005; 26: 786-91
40. Shehab-Eldin W, Zaki A, Gazareen S, Shoker A: Susceptibility to hyperglycemia in patients with chronic kidney disease. Am J Nephrol, 2009; 29: 406-13
41. Chang AM, Smith MJ, Bloem CJ et al: Limitation of the homeostasis model assessment to predict insulin resistance and β-cell dysfunction in older people. JCEM, 2006; 91(2): 629-34